Mental Health

Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)

If approved, Fabhalta® will be the only medicine indicated to selectively target the underlying cause of C3G1, an ultra-rare, progressive kidney...

Ellucian Foundation Awards $600,000+ in PATH Scholarships to 47 Colleges and Universities Globally to Support Student Financial Success

Progress, Accomplishment, Thriving, Hope (PATH) scholarships address financial stressors affecting student mental health, retention and academic performance RESTON, Va., Feb....

HIMSS25: FDB to Spotlight Customer Success Stories and Innovative Drug Knowledge Solutions

From Integrating Real-Time Pharmacogenomics to Boosting Medication Adherence, Healthcare Organizations Are Realizing the Benefits of Advanced Medication Decision Support SOUTH...

Stork Club Launches the World’s First Comprehensive Care for Postpartum Depression to Help Employers Support Working Mothers

The solution features clinically proven digital diagnostics and therapy, delivering up to 20% immediate PPD symptom relief and 30-40% improvement...

error: Content is protected !!